|
⚲
|
| Keyboard |
| Flynn Patrick John
✚
|
|
|---|---|
| CIK # | 0001864871 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001864871] | |
| 4 | [0001864871] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| NRX Pharmaceuticals Inc | |
| Flynn Patrick John |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NRX Pharmaceuticals Inc NRXP
Common Stock, par value $0.001 per share
|
2022-11-28 | Buy | 2,500 | $1.25 | 3,125 |
|
NRX Pharmaceuticals Inc NRXP
Common Stock, par value $0.001 per share
|
2022-11-28 | Buy | 2,500 | $1.25 | 3,125 |
|
NRX Pharmaceuticals Inc NRXP
Common Stock, par value $0.001 per share
|
2022-11-28 | Buy | 2,500 | $1.25 | 3,125 |
|
NRX Pharmaceuticals Inc NRXP
Common Stock, par value $0.001 per share
|
2022-11-28 | Buy | 2,500 | $1.24 | 3,100 |
|
NRX Pharmaceuticals Inc NRXP
Common Stock, par value $0.001 per share
|
2022-11-28 | Buy | 1,750 | $1.25 | 2,188 |
|
NRX Pharmaceuticals Inc NRXP
Employee Stock Option · derivative
|
2022-10-21 | Grant | 162,660 | ||
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2021-05-24 | Grant | 35,209 | ||
|
NRX Pharmaceuticals Inc NRXP
Common Stock Warrant (Right to buy) · derivative
|
2021-05-24 | Grant | 692,639 | ||
|
NRX Pharmaceuticals Inc NRXP
Common Stock Warrant (Right to buy) · derivative
|
2021-05-24 | Grant | 692,639 | ||
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2021-05-24 | Grant | 362,332 | ||
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2021-05-24 | Grant | 35,209 |